Table 4

 Allele frequencies of UGT1A7 in patients with pancreatic diseases and healthy controls

AllelesCzech RepublicGermanyNetherlands
ACP (n = 76)ICP/HP (n = 110)CO (n = 638)ACP (n = 296)ICP/HP (n = 272)AP (n = 306)PC (n = 402)CO (n = 864)Alc CO (n = 60)ACP (n = 154)ICP/HP (n = 116)CO (n = 550)Alc CO (n = 186)
UGT1A7
    *10.320.390.360.350.390.340.330.330.250.380.410.370.42
    *20.250.240.230.250.210.240.250.250.270.200.220.230.22
    *3 0.43 0.36 0.40 0.39 0.40 0.42 0.40 0.42 0.48 0.40 0.35 0.40 0.35
    100.000.010.020.010.0040.0070.020.0060.000.020.020.010.00
    *110.000.000.000.000.000.000.000.000.000.000.000.000.00
SwitzerlandAll countries
AllelesACP (n = 110)ICP/HP (n = 32)PC (n = 70)CO (n = 766)AC (n = 636)ICP/HP (n = 532)AP (n = 306)PC (n = 472)CO (n = 2818)Alc CO (n = 246)
Odds ratio is given for the *3 allele v the other alleles.
ACP, alcoholic chronic pancreatitis; Alc CO, alcoholic control subjects; AP, acute pancreatitis; CI, confidence interval; CO, healthy control subjects; ICP/HP, idiopathic chronic pancreatitis/hereditary chronic pancreatitis; OR, odds ratio adjusted for age, sex, and country of origin; PC, pancreatic adenocarcinoma.
UGT1A7
    *10.370.340.260.360.360.390.340.320.350.38
    *20.280.220.330.220.240.220.240.260.230.23
    *3 0.34 0.44 0.40 0.41 0.39 0.38 0.42 0.40 0.41 0.39
    100.010.000.010.010.0060.0040.0070.0130.0070.00
    *110.000.000.000.0030.000.000.000.000.00040.00
OR0.900.951.020.910.95
95% CI0.74 to 1.100.75 to 1.200.78 to 1.340.73 to 1.130.71 to 1.29